NCT06991972 Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients
| NCT ID | NCT06991972 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Khyber Teaching Hospital |
| Condition | Vitiligo |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2025-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 80 participants in total. It began in 2025-03-01 with a primary completion date of 2025-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial aims to compare the efficacy of needling versus microneedling, both followed by narrowband UVB therapy, in achieving repigmentation in patients with localized stable non-segmental vitiligo.
Eligibility Criteria
Inclusion Criteria: * Both male and female * Age 15-60 years * Patients having vitiligo for more than 1 year Exclusion Criteria: * Patients with tendency of keloid formation or hypertrophic scarring * Patients with any bleeding disorder, coagulation defect or using anti platelets * Any local infection at the treatment site * Patients who had received systemic therapy in last 6 months
Contact & Investigator
Huma Gul Doctor, MBBS
PRINCIPAL INVESTIGATOR
Khyber Teaching Hospital
Frequently Asked Questions
Who can join the NCT06991972 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 60 Years, studying Vitiligo. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06991972 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT06991972 currently recruiting?
Yes, NCT06991972 is actively recruiting participants. Contact the research team at xaffar965@gmail.com for enrollment information.
Where is the NCT06991972 trial being conducted?
This trial is being conducted at Peshawar, Pakistan.
Who is sponsoring the NCT06991972 clinical trial?
NCT06991972 is sponsored by Khyber Teaching Hospital. The principal investigator is Huma Gul Doctor, MBBS at Khyber Teaching Hospital. The trial plans to enroll 80 participants.